Physician profile
Sadiq Mandani
NPI 1336165760
$433.55
in general payments reported to CMS, 2019-2025
11 companies · $54.59 in 2025
The $54.59 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $14.90 · 2021: $84.25 · 2024: $142 · 2025: $54.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $116.23 | 2024 | |
| Glaxosmithkline, LLC. | $85.30 | 2019-2024 | Bexsero, Rotarix, Pediarix |
| Tris Pharma INC | $69.20 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $28.94 | 2021-2025 | Qelbree |
| Cranial Technologies, INC | $25.26 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $23.10 | 2025 | Ryaltris |
| Ironshore Pharmaceuticals INC. | $22.07 | 2019 | |
| Pfizer INC. | $21.47 | 2019 | |
| Alk-Abello, INC | $14.53 | 2025 | Neffy |
| Sanofi Pasteur INC. | $14.14 | 2021 | |
| Merck Sharp & Dohme LLC | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadiq Mandani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.